We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
-$8.16B
(-7.4%)
Cap. Flow
-$11.8B
Cap. Flow
% of AUM
-11.46%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
4,113
New
322
Increased
874
Reduced
2,317
Closed
300
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$587M |
| 2 |
UBS Group
UBS
|
+$204M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$177M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$159M |
| 5 |
HES
Hess
HES
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$559M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$479M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$329M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$316M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.17% |
| 2 | Technology | 10.29% |
| 3 | Healthcare | 9.29% |
| 4 | Consumer Staples | 6.63% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
IRIDEX
IRIX
$15.5M
| $161K | ﹤0.01% |
+16,275
| New | +$160K |
|
3452
Smart Sand
SND
$203M
| $161K | ﹤0.01% |
18,065
+1,337
| +8% | +$15.2K |
|
|
MRTX
3453
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $161K | ﹤0.01% |
+44,217
| New | +$169K |
|
3454
Cornerstone Strategic Value Fund
CLM
$2.17B
| $160K | ﹤0.01% |
+10,262
| New | +$165K |
|
3455
BlackRock MuniYield New York Quality Fund
MYN
$373M
| $159K | ﹤0.01% |
12,200
| – | – |
|
3456
United States Natural Gas Fund
UNG
$458M
| $159K | ﹤0.01% |
1,464
+551
| +60% | +$63.9K |
|
|
WSR
3457
DELISTED
Whitestone REIT
WSR
| $159K | ﹤0.01% |
+12,992
| New | +$162K |
|
|
RFP
3458
DELISTED
Resolute Forest Products Inc.
RFP
| $159K | ﹤0.01% |
36,285
-8,278
| -19% | -$41.1K |
|
|
ASNA
3459
DELISTED
Ascena Retail Group, Inc.
ASNA
| $159K | ﹤0.01% |
3,703
-13,591
| -79% | -$784K |
|
3460
Teekay Tankers
TNK
$2.63B
| $157K | ﹤0.01% |
10,403
+344
| +3% | +$5.32K |
|
|
SNAK
3461
DELISTED
Inventure Foods, Inc.
SNAK
| $157K | ﹤0.01% |
+36,422
| New | +$149K |
|
|
MOBL
3462
DELISTED
MobileIron, Inc.
MOBL
| $156K | ﹤0.01% |
25,801
+11,264
| +77% | +$58.9K |
|
3463
Orion Group Holdings
ORN
$503M
| $155K | ﹤0.01% |
20,846
-6,351
| -23% | -$47.5K |
|
|
MYOV
3464
DELISTED
Myovant Sciences Ltd.
MYOV
| $155K | ﹤0.01% |
+13,222
| New | +$164K |
|
|
BBG
3465
DELISTED
Bill Barrett Corp
BBG
| $155K | ﹤0.01% |
50,465
-74,608
| -60% | -$278K |
|
|
NPTN
3466
DELISTED
NEOPHOTONICS CORP
NPTN
| $151K | ﹤0.01% |
19,474
-2,813
| -13% | -$23.8K |
|
3467
XBiotech
XBIT
$68.9M
| $149K | ﹤0.01% |
31,559
-6,213
| -16% | -$59.5K |
|
3468
Zumiez
ZUMZ
$328M
| $149K | ﹤0.01% |
12,034
-34,182
| -74% | -$522K |
|
|
FRED
3469
DELISTED
Fred's Inc
FRED
| $149K | ﹤0.01% |
16,140
-71,879
| -82% | -$954K |
|
|
CEMP
3470
DELISTED
Cempra, Inc.
CEMP
| $149K | ﹤0.01% |
32,382
-5,936
| -15% | -$23.4K |
|
|
OMED
3471
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $149K | ﹤0.01% |
44,484
-38,846
| -47% | -$161K |
|
3472
Tiptree Inc
TIPT
$678M
| $148K | ﹤0.01% |
21,073
+1,358
| +7% | +$9.19K |
|
3473
Ocular Therapeutix
OCUL
$1.89B
| $146K | ﹤0.01% |
15,795
+2,533
| +19% | +$24.5K |
|
3474
ImmunityBio
IBRX
$7.32B
| $145K | ﹤0.01% |
19,171
+3,939
| +26% | +$17K |
|
3475
Banco Santander
SAN
$200B
| $145K | ﹤0.01% |
22,509
-758,027
| -97% | -$4.71M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2017 Portfolio in Review
As of Q2 2017, Credit Suisse held 4,113 positions worth $103B, down 7.4% from $111B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $11.8B in Q2 2017, closing 300 positions and reducing 2,317 holdings. Its most notable exit was Yahoo Inc, an estimated $316M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Credit Suisse opened a new position in Altaba Inc worth $587M.
- Credit Suisse's largest Q2 2017 buy was Altaba Inc: 10,781,590 shares worth $587M.
- Credit Suisse added most to UBS Group in Q2 2017, an estimated $204M increase.
- Credit Suisse's biggest Q2 2017 reduction was US Bancorp, cutting an estimated $559M.
- Credit Suisse fully exited Yahoo Inc in Q2 2017, selling an estimated $316M.
- Credit Suisse's ten largest holdings make up 17% of its $103B portfolio in Q2 2017.
- Credit Suisse opened 322 new positions and closed 300 in Q2 2017.
- Credit Suisse's portfolio value fell 7.4% quarter-over-quarter to $103B.
Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.